Sunday, May 1, 2011
SaneVax criticizes FDA for approval of Roche's cobas HPV genotyping test
In an April 22, 2011 letter to FDA Commissioner; Dr. Margaret Hamburg, Norma Erickson on behalf of the SaneVax Inc. Board of Directors, criticized the FDA for not following its own guidelines and recommendations in approving Roche's cobas HPV Test for cervical cancer screening and for HPV-16 and HPV-18 genotyping.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment